Sarah E. Warren
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immune Response and Inflammation
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 30
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 8
- Immune cells in cancer 6
- Oncology 30
- Cancer Immunotherapy and Biomarkers 23
- CAR-T cell therapy research 11
- Co-authors
- Edward A. Miao (9 shared papers)Alan A. Aderem (7 shared papers)Dat P. Mao (5 shared papers)Irina A. Leaf (3 shared papers)Mark Damian Wewers (1 shared paper)Monica Dors (1 shared paper)Anasuya Sarkar (1 shared paper)Piper M. Treuting (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (6 papers)Journal of Translational Medicine (5 papers)Annals of Oncology (4 papers)Nature (3 papers)Nature Communications (3 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Sarah E. Warren
86 papers receiving 10.2k citations
Sarah E. Warren's Hit Papers
Peers
Comparison fields: 5 of 136
- Immunology 3.9k
- Oncology 3.0k
- Cancer Research 897
- Molecular Biology 4.0k
- Endocrinology 295
Countries citing papers authored by Sarah E. Warren
This map shows the geographic impact of Sarah E. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Warren more than expected).
Fields of papers citing papers by Sarah E. Warren
This network shows the impact of papers produced by Sarah E. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Warren. The network helps show where Sarah E. Warren may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah E. Warren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tertiary lymphoid structures improve immunotherapy and survival in melanoma Hit paper breakdown → | 2020 | 1726 |
| 2 | Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria Hit paper breakdown → | 2010 | 1127 |
| 3 | Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 Hit paper breakdown → | 2018 | 790 |
| 4 | Multiplex digital spatial profiling of proteins and RNA in fixed tissue Hit paper breakdown → | 2020 | 739 |
| 5 | Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome Hit paper breakdown → | 2010 | 658 |
| 6 | Gene expression markers of Tumor Infiltrating Leukocytes Hit paper breakdown → | 2017 | 589 |
| 7 | COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets Hit paper breakdown → | 2021 | 577 |
| 8 | 2018 | 339 | |
| 9 | The spatial landscape of lung pathology during COVID-19 progression Hit paper breakdown → | 2021 | 273 |
| 10 | 2019 | 270 | |
| 11 | 2007 | 247 | |
| 12 | Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Hit paper breakdown → | 2022 | 202 |
| 13 | 2020 | 177 | |
| 14 | 2020 | 169 | |
| 15 | 2008 | 161 | |
| 16 | 2020 | 156 | |
| 17 | 2019 | 144 | |
| 18 | 2019 | 138 | |
| 19 | 2010 | 123 | |
| 20 | 2003 | 120 |
About Sarah E. Warren
Sarah E. Warren is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Hematology, having authored 90 papers that have together received 10.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (11 papers), Single-cell and spatial transcriptomics (8 papers), Immune Cell Function and Interaction (8 papers), Inflammasome and immune disorders (8 papers), COVID-19 Clinical Research Studies (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Immunology (3.9k citations), Oncology (3.0k citations), Cancer Research (897 citations), Molecular Biology (4.0k citations) and Endocrinology (295 citations). Sarah E. Warren has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Edward A. Miao, Alan A. Aderem, Dat P. Mao, Irina A. Leaf, Mark Damian Wewers, Monica Dors, Anasuya Sarkar, Piper M. Treuting, Patrick J. Danaher and Richard Bonneau. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Translational Medicine, Annals of Oncology, Nature and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.